Back to Search Start Over

Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes

Authors :
Marie-Aleth Richard
Céline Clévy
Stéphanie Mallet
Yanis Préau
Sandrine Monestier
René Valéro
Jean-Jacques Grob
C. Gaudy
Noémie Dubois
Sophie Béliard
Hôpital de la Timone [CHU - APHM] (TIMONE)
Aix Marseille Université (AMU)
Hôpital de la Conception [CHU - APHM] (LA CONCEPTION)
Aix-Marseille Université - Faculté de médecine (AMU MED)
Nutrition, obésité et risque thrombotique (NORT)
Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
ProdInra, Migration
Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Diabetes Care, Diabetes Care, American Diabetes Association, 2015, 38 (11), pp.E182-E183. ⟨10.2337/dc15-1331⟩
Publication Year :
2015
Publisher :
American Diabetes Association, 2015.

Abstract

A 44-year-old Caucasian woman with no history of diabetes was admitted to the emergency department in 2014 for vomiting and confusion, with polyuria, polydipsia, and a very recent weight loss (15 days). Biological tests revealed severe hyperglycemia and diabetic ketoacidosis (glycemia 50.45 mmol/L, ketones 3+, pH 7.25, HCO3− 3 mEq/L), with acute renal failure (39 mL/min/1.73 m2) and elevated serum lipase. Pancreatitis was ruled out by an abdominal computed tomography scan. Intravenous insulin resulted in rapid glycemic control. Surprisingly, HbA1c was subnormal (6.85%). Furthermore, anti-GAD and anti-IA2 antibodies were negative and serum C-peptide was undetectable. All these parameters led to the unusual diagnosis of fulminant type 1 diabetes (FD). FD is a rare subtype of type 1 diabetes …

Details

ISSN :
19355548 and 01495992
Volume :
38
Database :
OpenAIRE
Journal :
Diabetes Care
Accession number :
edsair.doi.dedup.....93d69e90c2475bd27f2749f1b7a0c5e0
Full Text :
https://doi.org/10.2337/dc15-1331